The special two-hour flight will fly the path of totality during its peak shadow casting, led by former NASA astronaut and JSX pilot Bill Gregory. Photo via JSX

With Texas set to be the prime location for the Great North American Solar Eclipse, airlines are lining up to offer the best vantage point and that includes JSX: The private carrier is offering a once-in-a-lifetime in-flight experience to 12 people, to join a specialty flight from Dallas on Monday, April 8.

This special two-hour flight will fly the path of totality during its peak shadow casting, led by former NASA astronaut and JSX pilot Bill Gregory. Those onboard will receive eclipse viewing glasses for safe solar viewing, themed Solar Eclipse cocktails, and complimentary sun protection.

Flight 4824 will depart on April 8 from JSX’s dedicated hangar at Dallas-Love Field at 1 pm. Every occupant will get their own dedicated window seat for the best chance of viewing the total solar eclipse as the plane travels within the path of totality, circling Dallas, and landing back at the hangar by 3 pm.

Space enthusiasts looking for a unique vantage point from 30,000 feet up can enter the sweepstakes online now until March 14, for a free chance to view the solar phenomenon with a guest.

In addition to the sweepstakes, the hop-on air carrier is partnering with Dallas Love Field’s Frontiers of Flight Museum to identify two children in the local Texas community with an interest in STEM to experience the rare spectacle with a guardian.

Previously serving as NASA’s Space Shuttle Endeavour pilot and having completed 262 orbits and traveling nearly seven million miles in space, JSX’s Bill Gregory will navigate the solar eclipse with expert commentary throughout the flight. Before joining the JSX team, Bill also served as a former U.S. Air Force Lieutenant Colonel and has received numerous accolades for his professional achievements including the NASA Space Flight Medal, Defense Superior Service Medal, Meritorious Service Medal, and more.

“With Dallas taking claim as the biggest city in the path of totality, we are thrilled to make this ultra premium and rare viewing opportunity a reality via JSX,” says CEO Alex Wilcox. “We’re committed to prioritizing safe, simple, joy-filled flights for all and are ecstatic to be able to provide travelers with the ultimate JSX experience in tandem with this once-in-a-lifetime celestial event.”

Other airlines offering special eclipse flights include Southwest Airlines and Delta.

JSX is the flight experience that offers convenience at an accessible price point, from checking in at a dedicated hangar 20 minutes prior to departure to flying on a sleek 30-seat jet, to business class legroom, frictionless security, free high speed Starlink Wi-Fi, and in-seat power.

------

This article originally ran on CultureMap.

Behold the future JSX Aura Aero Era 19-seat hybrid-electric aircraft. Rendering courtesy of JSX

Texas company lines up hundreds electric-hybrid planes for takeoff

flying green

Hop-on jet service JSX is soaring into a more eco-friendly future with plans to acquire more than 300 hybrid-electric airplanes.

The Dallas-based air carrier revealed in a release that they'll add up to 332 small hybrid planes in 2028, allowing them to connect to smaller, underserved communities around the country.

"Following the Biden Administration’s call last week for the aviation industry to cut carbon emissions ... JSX expects to take delivery of its first hybrid-electric aircraft in 2028, shepherding the next chapter of regional aviation as the first in its category to adopt this impactful cutting-edge renewable energy technology," JSX says in the release. "While commercial airlines can serve just 480 airports in the United States, JSX’s small community-friendly Part 135 and Part 380 Public Charter operations, combined with the exceptional performance capabilities of these hybrid-electric airplanes, enables service opportunities to thousands of federally funded airports otherwise inaccessible to people who can’t own or charter an entire aircraft."

The new cutting-edge airplanes will come from manufacturers Electra, Aura Aero, and Heart Aerospace and will include:

  • up to 82 Electra eSTOL 9-seat aircraft (32 firm orders and 50 options)
  • up to 150 Aura Aero Era 19-seat planes (50 firm orders and 100 options)
  • up to 100 Heart Aerospace ES-30 30-seat planes (50 firm orders and 50 options)

JSX currently operates about 50 semi-private planes configured with 30 seats, from private terminals in major cities including Dallas (Love Field) and Houston (Hobby Airport), and in "leisure" markets such as Destin, Florida and the Bahamas. The company recently shifted part of its operational focus to small markets (such as Midland-Odessa).

JSX promises a "no crowds, no lines, and no fuss" travel experience, allowing customers to check in and "hop on" just 20 minutes before departure. The carrier recently came under fire from federal regulators and major commercial airlines for its looser security regulations that more closely resemble those of charter providers than those of domestic airlines.

JSX is now doubling down on its pledge to service underserved cities, declaring in the release, "JSX has mastered the trifecta of marketing, selling, and operating attainable by-the-seat public charter air service to numerous small communities that have no other regular air service."


The future Heart Aerospace ES-30 30-seat hybrid-electric aircraft in JSX livery. Rendering courtesy of JSX


The new smaller, electric-hybrid aircraft will allow JSX to "dramatically lower the cost of its service and open new flight options at over 2,000 U.S. airports," they say, "stimulating local economies and empowering regional mobility and connectivity for communities devoid of regular air service today."

They point specifically to Del Rio, Texas, which has lost all commercial air service since the pandemic, they say, as an example of a small city that now can be reconnected to major cities in a cost-effective, sustainable way.

"The favorable operating economics of the Aura Aero Era, Heart ES-30, and Electra eSTOL can create thousands of new and expanded air travel options across the United States without the need for government subsidy," the company says.

In a statement, JSX CEO and cofounder Alex Wilcox adds, "As the network airlines order ever-larger aircraft it is inevitable that more and more small markets will be abandoned. Electra, Aura Aero, and Heart Aerospace are visionary organizations that share in JSX’s commitment to serving smaller communities, working together with us to weave sustainable regional air travel back into the fabric of American commerce and freedom of movement.”

———

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.